Mintz has advised Lisata Therapeutics. Lisata Therapeutics, a clinical-stage pharmaceutical company, has closed a $225 million private placement financing as part of a transaction that combines...
Lisata Therapeutics Completes $225 Million Private Placement
Lisata Therapeutics Acquires Marea Therapeutics
Mintz has advised Lisata Therapeutics. Goodwin Procter served Marea Therapeutics. Cooley assisted the placement agents. Lisata Therapeutics, Inc. (Nasdaq: LSTA) a clinical-stage pharmaceutical company, has acquired...
Berto Acquisition Corp. II Raises $315 Million in Upsized IPO Focused on AI and Infrastructure
White & Case LLP has advised Berto Acquisition Corp. II. Mintz has advised Needham & Company, LLC. Berto Acquisition Corp. II has closed its upsized initial...
Intensity Therapeutics Announces $2.3 Million Public Offering of Common Stock
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo has advised Intensity Therapeutics, Inc.; Sullivan & Worcester has advised ThinkEquity LLC. Intensity Therapeutics, Inc. has announced the pricing...
Orgenesis’ $1.1 Million Common Stock Offering
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo represented Orgenesis Inc. in the offering, and Sichenzia Ross Ference Carmel represented Titan Partners Group, an institutional investor. Orgenesis...
Genesis Growth Tech Acquisition Corp.’s Merger with Biolog-ID
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., Charles Russell Speechlys and Carey Olsen served as legal counsel to Biolog-id. O’Melveny & Myers LLP, Allen &...